Brain-derived neurotrophic factor induces rat bone marrow stromal cells to differentiate into neuron-like cells in vitro

Abstract

Abstract: Objective To investigate brain-derived neurotrophic factor (BDNF)-induced differentiation of rat bone marrow stromal cells (MSCs) into neuron-like cells in vitro and observe its neuroprotective effect of BNDF on the differentiated cells, which might provide the better seed cells for treatment of nervous system diseases. Methods The fifth-passage MSCs were induced by BDNF and 2-mercapto ethanol(β-ME)respectively, 1, 3 and 6 h after which the induced neuron-like cells were counted and compared. At 3 h, the neuron-like cells were identified by the immunocytochemical staining, reverse transcriptase polymerase chain reaction (RT-PCR) and Western blotting. Results The two induced cells both displayed neuronal morphologies with long and multipolar cell projections, but BDNF-induced cells survived for a longer time than γ-ME-induced ones. The results of immunocytochemical staining showed that the two neuron-like cells expressed nestin, neuron-specific enolase (NSE), neurofilament (NF), microtubule-associated protein (MAP-2), but not glial fibrillary acidic protein (GFAP). RT-PCR detected mRNA-positive NSE, NF and MAP-2 in the induced cells, with also mild positive GFAP mRNA. Western blotting identified also NSE expression in these neuron-like cells. Conclusion BDNF alone may induce rat MSCs to differentiate into neuron-like cells in vitro, which have longer lifetime to better serve the purpose of transplantation and gene therapy for nervous system diseases.

CLC Number:

R338.8

HUANG Wen, ZHANG Cheng, CHEN Song-lin, ZHANG Wei-xi, YAO Xiao-li, ZENG Ying, HUANG Hui, FENG Shan-wei, LIU Tai-yun. Brain-derived neurotrophic factor induces rat bone marrow stromal cells to differentiate into neuron-like cells in vitro[J]. Journal of Southern Medical University, 2004, 24(08): 854-858.

References

[1] Woodbury D, Schwarz EJ, Prockop DJ, et al. Adult rat and human bone marrow stromal cells differentiate into neurons[J]. J Neurosci Res, 2000, 61: 364-70.
[2] Sanchez Ramos J, Song S, Cardozo Pelae F, et al. Adult bone marrow stromal cells differentiate into neuroal cells in vitro[J]. Exp Neurol,2000, 164(2): 247-56.
[3] Wang L, Li Y, Lu DY, et al. Neurotrophins promote bone marrow stromal cells (MSCs) to express neural proteins in vitro[J]. Stroke,2001, 32: 334.
[4] Frim DM, Uhler TA, Galpern WR, et al. Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat[J]. Proc Natl Acad Sci USA, 1994, 91: 5104- 8.
[5] Zhao LR, Duan WM, Reyes M, et al. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats[J]. Exp Neurol, 2002,74(1): 11-20.
[6] Chen J, Zhang ZG, Li Y, et al. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats[J]. Circ Res, 2003, 92(6): 579-82.
[7] 杨于嘉,周燕,宋元宗,等.黄芩甙诱导大鼠骨髓基质细胞向神经细胞分化的研究[J].中华医学杂志,2002,82(19):1337-41.Yang YJ, Zhou Y, Song YZ, et al. Differentiation of rat bone marrow stromal cells into neuron induced by baicalin[J]. Natl Med J China, 2002, 82(19): 1337-41.
[8] 李中,张成,陈国俊,等.骨髓间质干细胞移植治疗MNO鼠后肌组织的超微结构改变[J].第一军医大学学报,2004,24(5):501-4.Li Z, Zhang C, Chen GJ, et al. Ultrastructure changes in musclar tissue of dystrophin/utrophin double knock out mice after bone marrow-derived mesenchymal stem cell transplantation[J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 2004, 24(5): 50l-4.
[9] Mazzini L, Fagioli F, Boccaletti R, et al. Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans[J].Amyotroph Lateral Scler Other Motor Neuron Disord, 2003, 4(3):158-61.
[10] Koc ON, Day J, Nieder M, et al. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH)[J]. Bone Marrow Transplant, 2002, 30(4): 215-22.
[11] Horwitz EM. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta[J]. Nat Med, 1999, 5: 309-13.